Physiomics Plc (LON:PYC – Get Free Report)’s stock price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 0.66 ($0.01) and traded as low as GBX 0.42 ($0.01). Physiomics shares last traded at GBX 0.42 ($0.01), with a volume of 1,127,284 shares trading hands.
Physiomics Price Performance
The stock’s 50 day moving average price is GBX 0.66 and its two-hundred day moving average price is GBX 0.69. The firm has a market capitalization of £861,684.12, a price-to-earnings ratio of -0.94 and a beta of 1.69.
Physiomics (LON:PYC – Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The company reported GBX (0.12) ($0.00) earnings per share (EPS) for the quarter. Physiomics had a negative net margin of 106.80% and a negative return on equity of 127.68%. As a group, equities research analysts anticipate that Physiomics Plc will post -0.13 EPS for the current fiscal year.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Recommended Stories
- Five stocks we like better than Physiomics
- Buy P&G Now, Before It Sets A New All-Time High
- Energy Transfer: Powering Data With Dividends and Diversification
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Qualcomm Stock Is Coiling for a Breakout
- Why Invest in 5G? How to Invest in 5G Stocks
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.